Does Central Nervous System Depressants Interact with Olopatadine Hydrochloride And Mometasone Furoate?
CDI records a moderate classification for Central Nervous System Depressants and Olopatadine Hydrochloride And Mometasone Furoate. The stored summary is: Concurrent use with CNS depressants should be avoided due to risk of somnolence and impairment of CNS performance. The mechanism involves additive central nervous system depression. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive central nervous system depression
What To Tell Your Doctor or Pharmacist
If you are taking Central Nervous System Depressants and your doctor is considering prescribing Olopatadine Hydrochloride And Mometasone Furoate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider